线 发表于 2025-3-23 13:01:49

Submitted on: 03 June 2013.
Revised on: 03 July 2013.
Accepted on: 11 July 2013.
Recent Advances in Inflammation & Allergy Drug Discovery

长处 发表于 2025-3-23 16:39:35

http://reply.papertrans.cn/3/262/26157/26157-12.png

流动性 发表于 2025-3-23 19:55:56

Submitted on: 22 July 2001.
Revised on: 08 August 2001.
Accepted on: 27 August 2001.
Recent Advances in Inflammation & Allergy Drug Discovery

Certainty 发表于 2025-3-23 23:00:47

Submitted on: 05 February 2004.
Revised on: 18 February 2004.
Accepted on: 03 March 2004.
Recent Advances in Inflammation & Allergy Drug Discovery

放气 发表于 2025-3-24 05:49:05

http://reply.papertrans.cn/3/262/26157/26157-15.png

Graduated 发表于 2025-3-24 09:51:44

Submitted on: 01 September 2022.
Revised on: 09 September 2022.
Accepted on: 24 September 2022.
Recent Advances in Inflammation & Allergy Drug Discovery

medieval 发表于 2025-3-24 12:53:55

Submitted on: 23 February 2001.
Revised on: 25 March 2001.
Accepted on: 11 April 2001.
Recent Advances in Inflammation & Allergy Drug Discovery

Feigned 发表于 2025-3-24 17:02:27

Submitted on: 24 January 2003.
Revised on: 21 February 2003.
Accepted on: 05 March 2003.
Recent Advances in Inflammation & Allergy Drug Discovery

ASSAY 发表于 2025-3-24 19:02:46

http://reply.papertrans.cn/3/262/26157/26157-19.png

鲁莽 发表于 2025-3-25 02:27:23

Submitted on: 24 May 2011.
Revised on: 07 July 2011.
Accepted on: 15 July 2011.
Recent Advances in Inflammation & Allergy Drug Discovery
页: 1 [2] 3 4
查看完整版本: ESCI期刊Recent Advances in Inflammation & Allergy Drug Discovery 2024/2025影响因子:1.294 (RECENT ADV INFLAMM A) (2772-2708).